Related Experiment Video
Updated: Jun 16, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Genetic testing and human leukocyte antigen in patients with hypertrophic cardiomyopathy and connective tissue
Daigo Hiraya1, Nobuyuki Murakoshi1, Miyako Igarashi1
1Department of Cardiology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.
Insights
Investigating obstructive hypertrophic cardiomyopathy (HOCM) in patients with connective tissue diseases reveals genetic variants and common human leukocyte antigen (HLA) types. These findings highlight the complex origins of HOCM, especially when inflammatory conditions are present.
Area of Science:
- Cardiology
- Genetics
- Immunology
Background:
- Hypertrophic cardiomyopathy (HCM) is often genetic, linked to sarcomere protein gene mutations (e.g., MYH7, MYBPC3), but many cases lack identified mutations.
- Associations between HCM, human leukocyte antigen (HLA) types, and connective tissue diseases (CTDs) are suggested but not well-defined.
- Understanding these links is crucial for diagnosing and treating HCM, particularly obstructive forms (HOCM).
Purpose of the Study:
- To investigate the genetic and HLA profiles of patients with obstructive hypertrophic cardiomyopathy (HOCM) and connective tissue diseases.
- To determine the prevalence of genetic variants and specific HLA types in this patient cohort.
- To explore potential correlations between HOCM, CTDs, and HLA types.
Main Methods:
- Single-center study analyzing five patients with HOCM, connective tissue diseases, and sarcoidosis.
- Detailed genetic analysis to identify variants in known HCM causative genes.
- HLA typing to assess the prevalence of specific human leukocyte antigen types.
Main Results:
- Rare variants in HCM causative genes were identified in two of the five analyzed patients.
- Specific human leukocyte antigen (HLA) types were found to be relatively common in the study group.
- Fifteen percent of all evaluated HOCM cases were associated with connective tissue diseases, predominantly rheumatoid arthritis.
Conclusions:
- HCM etiology is complex, involving genetic factors, HLA types, and potentially autoimmune or inflammatory conditions like CTDs.
- The frequent co-occurrence of HOCM and CTDs suggests a potential link requiring further investigation.
- Findings may inform improved diagnostic strategies and targeted therapies for HOCM patients with coexisting inflammatory diseases.
Abstract:
Hypertrophic cardiomyopathy (HCM) is caused by myocardial hypertrophy, often due to mutations in cardiac sarcomere protein genes such as beta-myosin heavy chain (MYH7) and myosin-binding protein C (MYBPC3). However, a significant proportion of HCM cases lack identified genetic mutations, and genotype-phenotype correlations remain unclear. Concurrently, potential associations between HCM and human leukocyte antigen (HLA) types, as well as connective tissue diseases, have been proposed. In this single-center study, we aimed to investigate the genetic and HLA profiles of patients with obstructive hypertrophic cardiomyopathy (HOCM) and connective tissue diseases, particularly focusing on the prevalence of genetic variants and HLA types. We conducted a detailed analysis of five patients with HOCM and connective tissue diseases and sarcoidosis, identifying rare variants in causative genes for HCM in two cases and observing specific HLA types that were relatively common. Notably, 15% of all HOCM cases presented with connective tissue diseases, mainly rheumatoid arthritis. These findings underscore the complexity of HCM etiology and suggest potential implications for both diagnostic strategies and therapeutic approaches in patients with concomitant inflammatory conditions.
More Related Videos
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

